MDx/CDx Focus: Another CDx Deal for Dako, Amgen; NYDOH Clears Enzo to Market ColonSentry
February 22, 2012
MDx/CDx Focus: Another CDx Deal for Dako, Amgen; NYDOH Clears Enzo to Market ColonSentry
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Royalties Drive up GeneNews Q1 Revenues Sharply
May 16, 2013 / GenomeWeb Daily News - MDx/CDx Focus: Austin Breast Center Offers BrevaGen; Epigenomics Studies Colon Cancer MDx vs FIT
April 11, 2012 / Pharmacogenomics Reporter - Oxford Gene Technology Licenses Colorectal Cancer Biomarkers from Norwegian Parties
February 22, 2012 / GenomeWeb Daily News - Yale Researcher Suggests More Focus on EGFR Isoforms Needed in Development of Antibody-Based Drugs
May 20, 2011 / ProteoMonitor - GeneNews Expected to Debut ColonSentry in New York by Year's End
September 1, 2010 / The Sample